Not applicableStudy completedNCT05611216
What this trial is testing
Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation
Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 164